NES and microcephaly: Instead, heterozygous Tg(Nes-cre)1Wme/J mice and tamoxifen-treated mice carrying a weakly-expressed Nes-CreERT2 transgene do not have microencephaly and hydrocephalus25, thereby pointing to increased transgene copy number and therefore higher Cre/CreER expression levels as the determinant of toxicity.